IBA Molecular, Piramal Imaging sign agreement for 18F-Florbetaben distribution
IBA Molecular will manufacture and distribute 18F-Florbetaben, an imaging agent from Piramal Imaging, under terms of an agreement reached between the two companies.

Dulles, Va.-based IBA Molecular will distribute the agent, which is currently in development for use with PET imaging for the detection of beta-amyloid plaques in the brain, in the European and U.S. markets.

Piramal recently acquired the intellectual property, worldwide development, marketing and distribution rights of the lead compound 18F-Florbetaben to form the Piramal Imaging subsidiary.